Olema Pharmaceuticals (OLMA) EPS (Basic) (2020 - 2026)
Olema Pharmaceuticals (OLMA) posted quarterly EPS (Basic) of -$1.41 for Q1 2026, down 280.74% year-over-year from $0.78 in Q1 2025, and down 164.81% quarter-over-quarter from -$0.53 in Q4 2025.
Powered by 
Analysis
Olema Pharmaceuticals (OLMA) EPS (Basic) (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has reported EPS (Basic) for 7 consecutive years, with -$1.41 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 280.74% year-over-year to -$1.41; the TTM figure through Mar 2026 stood at -$2.72 (down 9.71% YoY), while the FY2025 annual figure was -$4.58, down 96.07% from the prior year.
- EPS (Basic) declined to -$1.41 in Q1 2026 per OLMA's latest filing, from -$0.53 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.37 in Q1 2025 and bottomed at -$1.68 in Q3 2023.
- Historically, EPS (Basic) has averaged -$0.88 across 5 years, with a median of -$0.67 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 78.5% — and 2026, when it sank 280.74%.
- Olema Pharmaceuticals' EPS (Basic) stood at -$0.66 in 2022, then increased by 9.75% to -$0.6 in 2023, then advanced by 4.09% to -$0.58 in 2024, then advanced by 7.31% to -$0.53 in 2025, then tumbled by 164.81% to -$1.41 in 2026.
- Business Quant data shows OLMA's EPS (Basic) at -$1.41 in Q1 2026, -$0.53 in Q4 2025, and -$0.5 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Olema Pharmaceuticals | 1.13 Bn | 1.13 Bn | - | -0.60 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.60 |
| Mar 31, 2026 | -0.52 |
| Dec 31, 2025 | -0.53 |
| Sep 30, 2025 | -0.49 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.36 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.54 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -0.59 |
| Sep 30, 2023 | -0.48 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.70 |
| Dec 31, 2022 | -0.66 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -0.82 |
| Mar 31, 2022 | -0.58 |
| Dec 31, 2021 | -0.55 |
| Sep 30, 2021 | -0.45 |